Sheaff Brock Investment Advisors LLC raised its holdings in Chimera Investment Co. (NYSE:CIM – Get Rating) by 9.8% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 12,329 shares of the real estate investment trust’s stock after buying an additional 1,097 shares during the quarter. Sheaff Brock Investment Advisors LLC’s holdings in Chimera Investment were worth $148,000 at the end of the most recent quarter.
A number of other large investors have also recently made changes to their positions in the business. Gables Capital Management Inc. grew its position in shares of Chimera Investment by 2.6% in the 4th quarter. Gables Capital Management Inc. now owns 38,000 shares of the real estate investment trust’s stock worth $573,000 after buying an additional 950 shares during the last quarter. Strs Ohio grew its position in shares of Chimera Investment by 2.9% in the 1st quarter. Strs Ohio now owns 55,900 shares of the real estate investment trust’s stock worth $673,000 after buying an additional 1,600 shares during the last quarter. Lazard Asset Management LLC lifted its stake in shares of Chimera Investment by 16.3% in the 4th quarter. Lazard Asset Management LLC now owns 12,718 shares of the real estate investment trust’s stock valued at $191,000 after purchasing an additional 1,781 shares during the period. Commonwealth Equity Services LLC lifted its stake in shares of Chimera Investment by 1.3% in the 4th quarter. Commonwealth Equity Services LLC now owns 156,285 shares of the real estate investment trust’s stock valued at $2,356,000 after purchasing an additional 1,963 shares during the period. Finally, Victory Capital Management Inc. lifted its stake in shares of Chimera Investment by 2.9% in the 1st quarter. Victory Capital Management Inc. now owns 78,101 shares of the real estate investment trust’s stock valued at $783,000 after purchasing an additional 2,216 shares during the period. 53.05% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
A number of research analysts have recently commented on CIM shares. Barclays lowered their target price on Chimera Investment from $11.00 to $9.00 and set an “underweight” rating for the company in a research note on Monday, July 18th. Credit Suisse Group lowered their target price on Chimera Investment to $9.50 in a research note on Friday, July 22nd.
Chimera Investment Trading Up 0.4 %
Chimera Investment (NYSE:CIM – Get Rating) last announced its quarterly earnings data on Thursday, August 4th. The real estate investment trust reported $0.31 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.06). The company had revenue of $116.89 million for the quarter, compared to analysts’ expectations of $131.19 million. Chimera Investment had a negative net margin of 8.93% and a positive return on equity of 12.47%. The firm’s quarterly revenue was down 32.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.54 EPS. Equities research analysts predict that Chimera Investment Co. will post 1.46 earnings per share for the current fiscal year.
Chimera Investment Profile
Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The company, through its subsidiaries, invests in a portfolio of mortgage assets, including residential mortgage loans, agency and non-agency residential mortgage-backed securities, agency mortgage-backed securities secured by pools of residential, commercial mortgage loans, and other real estate related securities.
- Get a free copy of the StockNews.com research report on Chimera Investment (CIM)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc’s Revenues Are Up, Is It Time to Buy?
- Beyond Meat Is Not Beyond Hope, And It’s Cheap
- Why Apple Could Be At All-Time Highs By Year End
Receive News & Ratings for Chimera Investment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chimera Investment and related companies with MarketBeat.com's FREE daily email newsletter.